Human skin tissue – safety tests & procedures

Genoskin’s human skin models are created from real human skin tissue, which implies that they hold the same characteristics as real in vivo human skin. This approach opens up a wide range of testing possibilities for the pharmaceutical, cosmetic and chemical industry but also implies that our human skin models reflect the characteristics of their donor’s health.

Standard tested skin tissue for safer testing

All our human skin samples and models are obtained through donation after plastic surgery procedures on abdomen. The skin tissue is collected just after the operation, stored at 4°C before being processed by following a very strict safety protocol that is in full compliance with all applicable regulations and ethical requirements. The donated skin is then processed in a quality and temperature controlled environment.

In respect of the Declaration of Helsinki, we never hold details on the identity of our donors. However, we test the human skin tissue we collect on safety and make sure it is free of:

Hepatitis B
Hepatitis C
HIV 1 & 2

Additional product specifications

To make sure our human skin tissue not only answers the safety requirements you need for optimal testing, but also helps to guide your research, we provide additional information on:

Donor age
Donor gender
Donor skin type
Common allergies, such as atopy, food allergies, hay fever…
Particular skin conditions, such as eczema & psoriasis
Specific dermatological treatments, such as corticosteroids

Skin type of samples generally range from 1 to 3 of the Fitzpatrick Scale and donors are mainly of female origin. It is important to note that real human skin tissue will always reflect the genetic and biological characteristics of the donor.

We have signed Biological Sample Transfer agreements with various hospitals and clinics in France, which means that we have a weekly arrival of donated skin from several donors. However, to make sure our safety testing procedures can be conducted in due time, we need to be informed of your order two weeks before the expected delivery date.